178 related articles for article (PubMed ID: 9209362)
21. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
[TBL] [Abstract][Full Text] [Related]
22. A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients.
Oram SH; Thoms JA; Pridans C; Janes ME; Kinston SJ; Anand S; Landry JR; Lock RB; Jayaraman PS; Huntly BJ; Pimanda JE; Göttgens B
Oncogene; 2010 Oct; 29(43):5796-808. PubMed ID: 20676125
[TBL] [Abstract][Full Text] [Related]
23. The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development.
McCormack MP; Forster A; Drynan L; Pannell R; Rabbitts TH
Mol Cell Biol; 2003 Dec; 23(24):9003-13. PubMed ID: 14645513
[TBL] [Abstract][Full Text] [Related]
24. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
[TBL] [Abstract][Full Text] [Related]
25. Disruption of T-cell differentiation precedes T-cell tumor formation in LMO-2 (rhombotin-2) transgenic mice.
Neale GA; Rehg JE; Goorha RM
Leukemia; 1997 Apr; 11 Suppl 3():289-90. PubMed ID: 9209368
[TBL] [Abstract][Full Text] [Related]
26. The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion.
Nam CH; Rabbitts TH
Mol Ther; 2006 Jan; 13(1):15-25. PubMed ID: 16260184
[TBL] [Abstract][Full Text] [Related]
27. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
Ferrando AA; Neuberg DS; Dodge RK; Paietta E; Larson RA; Wiernik PH; Rowe JM; Caligiuri MA; Bloomfield CD; Look AT
Lancet; 2004 Feb; 363(9408):535-6. PubMed ID: 14975618
[TBL] [Abstract][Full Text] [Related]
28. LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes.
Rabbitts TH
Genes Dev; 1998 Sep; 12(17):2651-7. PubMed ID: 9732263
[No Abstract] [Full Text] [Related]
29. Identification of genes potentially involved in LMO2-induced leukemogenesis.
Davenport J; Neale GA; Goorha R
Leukemia; 2000 Nov; 14(11):1986-96. PubMed ID: 11069036
[TBL] [Abstract][Full Text] [Related]
30. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.
Robb L; Begley CG
Bioessays; 1997 Jul; 19(7):607-13. PubMed ID: 9230693
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional control of fetal liver hematopoiesis: dominant negative effect of the overexpression of the LIM domain mutants of LMO2.
Terano T; Zhong Y; Toyokuni S; Hiai H; Yamada Y
Exp Hematol; 2005 Jun; 33(6):641-51. PubMed ID: 15911088
[TBL] [Abstract][Full Text] [Related]
32. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
Ferrando AA; Neuberg DS; Staunton J; Loh ML; Huard C; Raimondi SC; Behm FG; Pui CH; Downing JR; Gilliland DG; Lander ES; Golub TR; Look AT
Cancer Cell; 2002 Feb; 1(1):75-87. PubMed ID: 12086890
[TBL] [Abstract][Full Text] [Related]
33. The expression of LMO2 protein in acute B-cell and myeloid leukemia.
Cobanoglu U; Sonmez M; Ozbas HM; Erkut N; Can G
Hematology; 2010 Jun; 15(3):132-4. PubMed ID: 20557670
[TBL] [Abstract][Full Text] [Related]
34. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
Gering M; Yamada Y; Rabbitts TH; Patient RK
Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
[TBL] [Abstract][Full Text] [Related]
35. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation.
Visvader JE; Mao X; Fujiwara Y; Hahm K; Orkin SH
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13707-12. PubMed ID: 9391090
[TBL] [Abstract][Full Text] [Related]
36. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
Baer R
Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
[TBL] [Abstract][Full Text] [Related]
37. Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19).
Hirose K; Inukai T; Kikuchi J; Furukawa Y; Ikawa T; Kawamoto H; Oram SH; Göttgens B; Kiyokawa N; Miyagawa Y; Okita H; Akahane K; Zhang X; Kuroda I; Honna H; Kagami K; Goi K; Kurosawa H; Look AT; Matsui H; Inaba T; Sugita K
Blood; 2010 Aug; 116(6):962-70. PubMed ID: 20519628
[TBL] [Abstract][Full Text] [Related]
38. Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
Ferrando AA; Herblot S; Palomero T; Hansen M; Hoang T; Fox EA; Look AT
Blood; 2004 Mar; 103(5):1909-11. PubMed ID: 14604958
[TBL] [Abstract][Full Text] [Related]
39. The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors.
de Boer J; Yeung J; Ellu J; Ramanujachar R; Bornhauser B; Solarska O; Hubank M; Williams O; Brady HJ
Leukemia; 2011 Feb; 25(2):321-30. PubMed ID: 21072044
[TBL] [Abstract][Full Text] [Related]
40. Transcription factors of the bHLH and LIM families: synergistic mediators of T cell acute leukemia?
Baer R; Hwang LY; Bash RO
Curr Top Microbiol Immunol; 1997; 220():55-65. PubMed ID: 9103675
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]